Kevzara and Blood disorders
Result of checking the interaction of drug Kevzara and disease Blood disorders for safety when used together.
When checking interaction based on authoritative sources Drugs.com, Rxlist.com, Webmd.com, Medscape.com there are contraindications or side effects that may cause harm or increase the negative effect from drug use in presence of concomitant diseases.
Consumer:The use of sarilumab is associate with higher incidence of decrease in absolute neutrophil count (ANC), including neutropenia and thrombocytopenia. It is recommended to assess neutrophil count and platelet count prior to initiation of therapy and monitor these levels 4 to 8 weeks after start of therapy and every 3 months thereafter. Dose modification may be necessary based on the pharmacodynamics of the changes in ANC. Care is recommended when using this agent in patients with blood disorders.
Generic Name: sarilumab
Brand Name: Kevzara, Kevzara Pre-filled Pen
Synonyms: n.a.
Kevzara - choroby krwi 
Kevzara - doenças sanguíneas 
Kevzara - gangguan darah 
Kevzara - kelainan darah 
Kevzara - disturbi del sangue 
Kevzara - troubles sanguins 
Kevzara - Bluterkrankungen 
Kevzara - trastornos de la sangre 
Kevzara - заболевания крови 
Kevzara - Kan hastalıkları 
Kevzara - اضطرابات الدم 
Kevzara - 血液疾病